Antibody Fragments Market: Global Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2017-2021 and Forecast 2022-2028

$ PRICE - $ 3,000.00$ 8,900.00

Antibody Fragments Market by Product Type (F(ab) fragment, F(ab’)2 fragment), By Application (Cancer, Immunodeficiency Disorders, Others) and Geography (North America, Europe, Asia Pacific, Latin America, and Middle East and Africa)

 

$ PRICE - $ 3,000.00$ 8,900.00
Clear selection
Clear
$ PRICE - $ 3,000.00$ 8,900.00
FacebookTwitterLinkedinEmail
SKU: N/A Categories: ,

Report

Description

Antibody Fragments Market size was valued at USD 16,450.0 million in 2021 and is poised to grow at a significant CAGR of 8.7% during forecast period 2022-28. Due to increase in prevalence of various types of cancers, immunodeficiency disorders, and other infectious diseases. Antibody fragments are parts of full-length antibodies that have been digested by papain or pepsin. The market is still in its early phases, and the majority of current antibody fragments research is focused on cancer and related disorders. Moreover, rise in global geriatric population, wide range of applications with the antibody fragments, and rise in R&D activities for the development of antibody fragments are the major factors that are driving the growth of the global antibody fragments market over the forecast timeframe. This report studies global market dynamics elaborately to indentify the current trends & drivers, future opportunities and possible challenges to the key stakeholders operating in the market. Global market report includes human demographics; regulatory scenario, and competition analysis with vividly illustrated the competition dashboard to assess the market competition. Moreover, PBI analyzed global antibody fragments market to better equip clients with possible investment opportunities across the regions (regional Investment Hot-Spots) and market unmet needs (Product Opportunities). The market for antibody fragments is being pushed by the rising prevalence of target diseases, the benefits of antibody fragments over full-length antibodies, and increased R&D spending. The tight regulatory standards for the approval of antibody fragments, as well as challenges in the purification of antibody fragments, are projected to stifle market expansion.

Antibody Fragments Market

MARKET SUMMARY
-
8.7%
  • Study Period– 2022-2028
  • Base Year– 2021
  • CAGR– 8.7%
  • Largest Market– North America
  • Fastest Growing Market– Europe

Antibody Fragments Market

  • The report on global Antibody Fragments Market gives historical, current, and future market sizes (US$ Mn) on the basis of product type, application and geography.
  • Antibody Fragments Market report gives comprehensive outlook across the region with special emphasis on key regions such as North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
  • Key stakeholders of the global antibody fragments market report include suppliers, manufacturers, marketers, policy makers, and healthcare service providers engaged in global antibody fragments products.
Key Players
  • Bristol-Myers Squibb Company (U.S.)
  • Eli Lilly and Company (U.S.)
  • F. Hoffmann-La Roche Ltd. (Switzerland)
  • Novartis AG (Switzerland)
  • Johnson & Johnson Services, Inc. (U.S.)
Dynamics

Antibody Fragments Market

Increase in the prevalence of cancer, immunodeficiency disorders, and infectious diseases is a key factor drive the global antibody fragments market. According to World Health Organization 2018, approximately 9.6 Mn death occurred due to cancer around the globe. moreover, product approval by the FDA for antibodies fragment, raise in funding for the R&D activities by public and private sectors are anticipated to propel the global antibody fragments market over the forecast years.


North-America got significant share

Antibody Fragments Market

North America accounted for larger revenue share in global antibody fragments market with significant CAGR. Increase in prevalence of cancer and other infectious diseases, rise in R&D activities for the development of antibody fragments, and rise in awareness about the antibody fragments among the healthcare professionals in U.S. and Canada are anticipated to propel the market. Europe antibody fragments market projected to grow at significant rate owing to increase in research and development on new products in the market for infectious disease treatment, favorable reimbursement policies, and increase in healthcare expenditure are expected to enhance the market.

Latin America
Latin-America
North-America
North-America
Europe
Europe
Asia Pacific
Asia-Pacific
Middle East
Middle East

Key

Key Features of the Report

  • The report provides granular level information about the market size, regional market share, historic market (2015-2020) and forecast (2021-2027)
  • The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
  •  The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments and startup’s details that are actively working in the market
  • The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario
  • The report analyses the impact of socio-political environment through PESTLE Analysis and competition through Porter’s Five Force Analysis in addition to recent technology advancements and innovations in the market

Key

Key Findings of the Report


Antibody Fragments Market Segmentation


Location

GEOGRAPHY

Frequently Asked Questions

2021 is the base year and 2028 is the forecast year.

The report covers the five regions and 15+ countries market data: North America (United States, Canada), Europe (Germany, France, Italy, Spain, and United Kingdom (UK), Asia Pacific (China, India, Japan, Australia & New Zealand), Latin America (Brazil, Mexico, Argentina) and Middle East and Africa (Saudi Arabia, United Arab Emirates, South Africa).

In our report, we provide 12-15 market players’ information into the report. However, based on the client’s request we will provide additional country and regional market players information as well.


Report

Table Of Content

1. Executive Summary

2. Global Antibody Fragments Market Introduction

2.1. Global Antibody Fragments Market – Taxonomy

2.2. Global Antibody Fragments Market –Definitions

2.2.1. Product Type

2.2.2. Application

3. Global Antibody Fragments Market Dynamics

3.1. Drivers

3.2. Restraints

3.3. Opportunities/Unmet Needs of the Market

3.4. Trends

3.5. Global Antibody Fragments Market Dynamic Factors – Impact Analysis

3.6. Global Antibody Fragments Market – Competition Landscape

3.7. Epidemiology

4. Global Antibody Fragments Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025

4.1. Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 (Revenue, USD Mn)

4.2. Year-over-Year (Y-o-Y) Growth Analysis (%)

4.3. Market Opportunity Analysis

5. Global Antibody Fragments Market, By Product Type, 2014 – 2018 and Forecast, 2019 – 2025 (Revenue, USD Mn)

5.1. F(ab) Fragment

5.1.1. Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 (Revenue, USD Mn)

5.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

5.1.3. Market Opportunity Analysis

5.2. F(ab’)2 Fragment

5.2.1. Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 (Revenue, USD Mn)

5.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

5.2.3. Market Opportunity Analysis

6. Global Antibody Fragments Market Forecast, By Application, 2014 – 2018 and Forecast, 2019 – 2025

6.1. Cancer

6.1.1. Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 (Revenue, USD Mn)

6.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

6.1.3. Market Opportunity Analysis

6.2. Immunodeficiency Disorders

6.2.1. Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 (Revenue, USD Mn)

6.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

6.2.3. Market Opportunity Analysis

6.3. Others

6.3.1. Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 (Revenue, USD Mn)

6.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

6.3.3. Market Opportunity Analysis

7. Global Antibody Fragments Market Forecast, By Region, 2014 – 2018 and Forecast, 2019 – 2025 (Revenue, USD Mn)

7.1. North America

7.1.1. Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 (Revenue, USD Mn)

7.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

7.1.3. Market Opportunity Analysis

7.2. Europe

7.2.1. Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 (Revenue, USD Mn)

7.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

7.2.3. Market Opportunity Analysis

7.3. Asia-Pacific

7.3.1. Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 (Revenue, USD Mn)

7.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

7.3.3. Market Opportunity Analysis

7.4. Latin America

7.4.1. Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 (Revenue, USD Mn)

7.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

7.4.3. Market Opportunity Analysis

7.5. Middle East and Africa

7.5.1. Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 (Revenue, USD Mn)

7.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

7.5.3. Market Opportunity Analysis

7.6. Global Antibody Fragments Market – Opportunity Analysis Index, By Product Type, By Application, and Region, 2019 – 2025

8. North America Antibody Fragments Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 (Revenue, USD Mn)

8.1. Product Type Analysis 2014 – 2018 and Forecast 2019 – 2025 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)

8.1.1. F(ab) Fragment

8.1.2. F(ab’)2 Fragment

8.2. Application Analysis 2014 – 2018 and Forecast 2019 – 2025 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)

8.2.1. Cancer

8.2.2. Immunodeficiency Disorders

8.2.3. Others

8.3. Country Analysis 2016 and Forecast 2019 – 2025 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)

8.3.1. U.S.

8.3.2. Canada

8.4. North America Antibody Fragments Market – Opportunity Analysis Index, By Product Type, By Application, and Country, 2019 – 2025

8.5. North America Antibody Fragments Market Dynamics – Trends

9. Europe Antibody Fragments Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 (Revenue, USD Mn)

9.1. Product Type Analysis 2014 – 2018 and Forecast 2019 – 2025 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)

9.1.1. F(ab) Fragment

9.1.2. F(ab’)2 Fragment

9.2. Application Analysis 2014 – 2018 and Forecast 2019 – 2025 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)

9.2.1. Cancer

9.2.2. Immunodeficiency Disorders

9.2.3. Others

9.3. Country Analysis 2014 – 2018 and Forecast 2019 – 2025 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)

9.3.1. Germany

9.3.2. UK

9.3.3. France

9.3.4. Spain

9.3.5. Italy

9.3.6. Russia

9.3.7. Poland

9.3.8. Rest of Europe

9.4. Europe Antibody Fragments Market – Opportunity Analysis Index, By Product Type, By Application, and Country,2019 – 2025

9.5. Europe Antibody Fragments Market Dynamics – Trends

10. Asia-Pacific Antibody Fragments Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 (Revenue, USD Mn)

10.1. Product Type Analysis 2014 – 2018 and Forecast 2019 – 2025 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)

10.1.1. F(ab) Fragment

10.1.2. F(ab’)2 Fragment

10.2. Application Analysis 2014 – 2018 and Forecast 2019 – 2025 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)

10.2.1. Cancer

10.2.2. Immunodeficiency Disorders

10.2.3. Others

10.3. Country Analysis 2014 – 2018 and Forecast 2019 – 2025 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)

10.3.1. Japan

10.3.2. China

10.3.3. India

10.3.4. ASEAN

10.3.5. Australia & New Zealand

10.3.6. Rest of Asia-Pacific

10.4. Asia-Pacific Antibody Fragments Market – Opportunity Analysis Index, By Product Type, By Application, and Country,2019 – 2025

10.5. Asia-Pacific Antibody Fragments Market Dynamics – Trends

11. Latin America Antibody Fragments Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 (Revenue, USD Mn)

11.1. Product Type Analysis 2014 – 2018 and Forecast 2019 – 2025 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)

11.1.1. F(ab) Fragment

11.1.2. F(ab’)2 Fragment

11.2. Application Analysis 2014 – 2018 and Forecast 2019 – 2025 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)

11.2.1. Cancer

11.2.2. Immunodeficiency Disorders

11.2.3. Others

11.3. Country Analysis 2014 – 2018 and Forecast 2019 – 2025 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)

11.3.1. Brazil

11.3.2. Mexico

11.3.3. Argentina

11.3.4. Venezuela

11.3.5. Rest of Latin America

11.4. Latin America Antibody Fragments Market – Opportunity Analysis Index, By Product Type, By Application, and Country, 2019 – 2025

11.5. Latin America Antibody Fragments Market Dynamics – Trends

12. Middle East and Africa Antibody Fragments Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 (Revenue, USD Mn)

12.1. Product Type Analysis 2014 – 2018 and Forecast 2019 – 2025 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)

12.1.1. F(ab) Fragment

12.1.2. F(ab’)2 Fragment

12.2. Application Analysis 2014 – 2018 and Forecast 2019 – 2025 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)

12.2.1. Cancer

12.2.2. Immunodeficiency Disorders

12.2.3. Others

12.3. Country Analysis 2014 – 2018 and Forecast 2019 – 2025 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)

12.3.1. Gulf Cooperation Council (GCC) Countries

12.3.2. Israel

12.3.3. South Africa

12.3.4. Rest of MEA

12.4. MEA Antibody Fragments Market – Opportunity Analysis Index, By Product Type, By Application, and Country, 2019 – 2025

12.5. MEA Antibody Fragments Market Dynamics – Trends

13. Competition Landscape

13.1. Strategic Dashboard of Top Market Players

13.2. Company Profiles (Introduction, Financial Analysis, Product Type& Service Offerings, Key Developments, Strategies, and SWOT Analysis)

13.2.1. Bristol-Myers Squibb Company (U.S.)

13.2.2. Eli Lilly and Company (U.S.)

13.2.3. F. Hoffmann-La Roche Ltd. (Switzerland)

13.2.4. Novartis AG (Switzerland)

13.2.5. Johnson & Johnson Services, Inc. (U.S.)

13.2.6. Amgen, Inc. (U.S.)

13.2.7. AbbVie, Inc. (U.S.)

13.2.8. Takeda Pharmaceutical Company Limited (Japan)

13.2.9. Sanofi S.A. (France)

13.2.10. Biogen, Inc. (U.S.)

14. Research Methodology

15. Key Assumptions and Acronyms


Report

Company Profile

  • Bristol-Myers Squibb Company (U.S.)
  • Eli Lilly and Company (U.S.)
  • F. Hoffmann-La Roche Ltd. (Switzerland)
  • Novartis AG (Switzerland)
  • Johnson & Johnson Services, Inc. (U.S.)
  • Amgen, Inc. (U.S.)
  • AbbVie, Inc. (U.S.)
  • Takeda Pharmaceutical Company Limited (Japan)
  • Sanofi S.A. (France)
  • Biogen, Inc. (U.S.)

Description

Antibody Fragments Market size was valued at USD 16,450.0 million in 2021 and is poised to grow at a significant CAGR of 8.7% during forecast period 2022-28. Due to increase in prevalence of various types of cancers, immunodeficiency disorders, and other infectious diseases. Antibody fragments are parts of full-length antibodies that have been digested by papain or pepsin. The market is still in its early phases, and the majority of current antibody fragments research is focused on cancer and related disorders. Moreover, rise in global geriatric population, wide range of applications with the antibody fragments, and rise in R&D activities for the development of antibody fragments are the major factors that are driving the growth of the global antibody fragments market over the forecast timeframe. This report studies global market dynamics elaborately to indentify the current trends & drivers, future opportunities and possible challenges to the key stakeholders operating in the market. Global market report includes human demographics; regulatory scenario, and competition analysis with vividly illustrated the competition dashboard to assess the market competition. Moreover, PBI analyzed global antibody fragments market to better equip clients with possible investment opportunities across the regions (regional Investment Hot-Spots) and market unmet needs (Product Opportunities). The market for antibody fragments is being pushed by the rising prevalence of target diseases, the benefits of antibody fragments over full-length antibodies, and increased R&D spending. The tight regulatory standards for the approval of antibody fragments, as well as challenges in the purification of antibody fragments, are projected to stifle market expansion.

ASIA PACIFIC OFFICE

Precision Business Insights, MIG 366, SAI PLAZA, 1st Floor, KPHB Colony, Hyderabad - 500072

EUROPE OFFICE

Precision Business Insights, Kemp House, 152 – 160 City Road, London EC1V 2NX